Johns Hopkins University researchers are working on a synthesized drug that may halt or even reverse atherosclerosis. The drug, known as D-PDMP, changed how fat was metabolized in tests with rabbits and mice, nearly eliminating built-up cholesterol in vital regions. "Our drug, we hope, will prevent [or] delay the rise in cholesterol and fat and thus prevent thickening/hardening of the blood vessel," said researcher Subroto Chatterjee. "This is like the use of Drano to clean up our plumbing at home."
Published in Brief: